MINNEAPOLIS--(BUSINESS WIRE)--A new study published in the American Journal of Rhinology and Allergy demonstrates the benefits of in-office balloon dilation for sufferers of chronic sinusitis. Results ...

A day after it publicly announced its new CEO, Entellus Medical Inc. has launched a new sinus-dilation tool. The company’s Xpress device uses a balloon catheter to dilate both the frontal and sphenoid ...

MINNEAPOLIS--(BUSINESS WIRE)--Entellus Medical, a Minnesota-based medical technology company, today announced the launch of its XprESS™ Multi-Sinus Dilation Tool during the Combined Otolaryngology ...

Entellus Medical, which sells a minimally invasive balloon sinus dilation treatment to open obstructed sinus pathways, filed on Tuesday with the SEC to raise up to $69 million in an initial public ...

Dublin, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The "North America Balloon Sinuplasty Systems Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The comprehensive databook ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted Entellus Medical 501(k) clearance for their XprESS Multi-Sinus dilation system in pediatric ...

Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, announced terms for its IPO on Thursday. The Plymouth, MN-based company plans to raise $70 million by ...

Minimally invasive sinus company Entellus Medical ($ENTL) hit the IPO trifecta in the first med tech IPO of the year. It priced at $17, at the top of its proposed ...

PLYMOUTH, Minn., April 12, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products ...